{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:22:01Z","timestamp":1772166121916,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003669","name":"Korea Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["2017E5400300"],"award-info":[{"award-number":["2017E5400300"]}],"id":[{"id":"10.13039\/501100003669","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Internal Research Program from the Armed Forces Medical Research Institute","award":["17-internal-7"],"award-info":[{"award-number":["17-internal-7"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most prevalent inborn disorder. This X-chromosome-linked recessive disease affects more than 400 million people globally, and is associated with haemolytic anaemia after medication with the anti-latent malaria drug, primaquine. To prevent malaria, the Republic of Korea (ROK) Army administers malaria chemoprophylaxis. Due to the previously low G6PD deficiency prevalence in the ROK, prior to primaquine administration, testing for G6PD deficiency was not mandatory. In this study, to evaluate the risk from malaria chemoprophylaxis in the ROK, G6PD deficiency prevalence was investigated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Blood specimens from 1632 soldiers entering training camp for the 3\n                      <jats:sup>rd<\/jats:sup>\n                      Infantry of the ROK Army were collected. CareStart\u2122 Biosensor for G6PD and haemoglobin (Hb) was used to detect G6PD levels. G6PD variants using the DiaPlexC G6PD Genotyping kit (Asian type) and full-length sequencing were examined.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 1632 blood specimens tested, none was observed to be G6PD deficient. The median value of all tested samples was 7.582 U\/g Hb. An investigation of 170 G6PD DNA variants was analysed and categorized as partially low normal [n\u2009=\u2009131, 30\u201380% (2.27\u20136.05\u00a0U\/g Hb) of the median value], high [n\u2009=\u20093, &gt;\u2009150% (&gt;\u200911.373\u00a0U\/g Hb) of the median value], or normal [n\u2009=\u200936, 80\u2013150% (6.05\u201311.373\u00a0U\/g Hb) of the median value], and none was amplified by the DiaPlexC kit. Five silent mutations (C\u2192T) in 131 partially low\u00a0normal specimens were found at the 1311th nucleotide position by sequence analysis. Another 8 silent mutations (T93C) were also detected in 131 partially low normal specimens. Thus, it is inferred that these silent mutations could be related to G6PD activity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This G6PD deficiency prevalence study, conducted among participants from the 3rd Infantry of the ROK Army, provided crucial evidence for the safety of malaria chemoprophylaxis. This study showed that the prevalence of G6PD deficiency among 1632 young soldiers was wholly absent. Although G6PD phenotypic mutations were not detected, many silent mutations (C1311T and T93C) were observed. Thus, it is inferred that malaria chemoprophylaxis is relatively safe against G6PD deficiency-mediated haemolytic anaemia. However, given the number of individuals whose G6PD were at the partially\u00a0low normal range and the frequent detection of G6PD deficiency-related mutations, consistent monitoring of G6PD deficiency is needed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12936-020-03393-4","type":"journal-article","created":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T11:03:51Z","timestamp":1598958231000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Investigation of glucose-6-phosphate dehydrogenase (G6PD) deficiency prevalence in a Plasmodium vivax-endemic area in the Republic of Korea (ROK)"],"prefix":"10.1186","volume":"19","author":[{"given":"Wonsig","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang-Eun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min Jun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5534-5338","authenticated-orcid":false,"given":"Kyung Tae","family":"Noh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,1]]},"reference":[{"key":"3393_CR1","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1042\/bj1380425","volume":"138","author":"LV Eggleston","year":"1974","unstructured":"Eggleston LV, Krebs HA. Regulation of the pentose phosphate cycle. Biochem J. 1974;138:425\u201335.","journal-title":"Biochem J."},{"key":"3393_CR2","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/0168-9525(92)90080-N","volume":"8","author":"T Vulliamy","year":"1992","unstructured":"Vulliamy T, Mason P, Luzzatto L. The molecular basis of glucose-6-phosphate dehydrogenase deficiency. Trends Genet. 1992;8:138\u201343.","journal-title":"Trends Genet"},{"key":"3393_CR3","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1182\/blood.V88.3.1084.1084","volume":"88","author":"GF Gaetani","year":"1996","unstructured":"Gaetani GF, Rolfo M, Arena S, Mangerini R, Meloni GF, Ferraris AM. Active involvement of catalase during hemolytic crises of favism. Blood. 1996;88:1084\u20138.","journal-title":"Blood"},{"key":"3393_CR4","doi-asserted-by":"publisher","first-page":"e1001339","DOI":"10.1371\/journal.pmed.1001339","volume":"9","author":"RE Howes","year":"2012","unstructured":"Howes RE, Piel FB, Patil AP, Nyangiri OA, Gething PW, Dewi M, et al. G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map. PLoS Med. 2012;9:e1001339.","journal-title":"PLoS Med."},{"key":"3393_CR5","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1007\/s10038-005-0279-z","volume":"50","author":"H Matsuoka","year":"2005","unstructured":"Matsuoka H, Nguon C, Kanbe T, Jalloh A, Sato H, Yoshida S, et al. Glucose-6-phosphate dehydrogenase (G6PD) mutations in Cambodia: G6PD Viangchan (871G>A) is the most common variant in the Cambodian population. J Hum Genet. 2005;50:468\u201372.","journal-title":"J Hum Genet"},{"key":"3393_CR6","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1046\/j.1365-3156.2000.00542.x","volume":"5","author":"P Verle","year":"2000","unstructured":"Verle P, Nhan DH, Tinh TT, Uyen TT, Thuong ND, Kongs A, et al. Glucose-6-phosphate dehydrogenase deficiency in northern Vietnam. Trop Med Int Health. 2000;5:203\u20136.","journal-title":"Trop Med Int Health."},{"key":"3393_CR7","first-page":"494","volume":"13","author":"N Saha","year":"1984","unstructured":"Saha N. Distribution of glucose-6-phosphate dehydrogenase phenotypes in five East Asian population groups. Ann Acad Med Singapore. 1984;13:494\u20137.","journal-title":"Ann Acad Med Singapore"},{"key":"3393_CR8","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1159\/000464706","volume":"14","author":"RQ Blackwell","year":"1968","unstructured":"Blackwell RQ, Ro IH, Yen L. Low incidence of erythrocyte G-6-PD deficiency in Koreans. Vox Sang. 1968;14:299\u2013303.","journal-title":"Vox Sang"},{"key":"3393_CR9","doi-asserted-by":"publisher","first-page":"e97390","DOI":"10.1371\/journal.pone.0097390","volume":"9","author":"YK Goo","year":"2014","unstructured":"Goo YK, Ji SY, Shin HI, Moon JH, Cho SH, Lee WJ, et al. First evaluation of glucose-6-phosphate dehydrogenase (G6PD) deficiency in vivax malaria endemic regions in the Republic of Korea. PLoS ONE. 2014;9:e97390.","journal-title":"PLoS ONE"},{"key":"3393_CR10","doi-asserted-by":"publisher","first-page":"79","DOI":"10.4269\/ajtmh.2007.77.79","volume":"77","author":"RN Price","year":"2007","unstructured":"Price RN, Tjitra E, Guerra CA, Yeung S, White NJ, Anstey NM. Vivax malaria: neglected and not benign. Am J Trop Med Hyg. 2007;77:79\u201387.","journal-title":"Am J Trop Med Hyg"},{"key":"3393_CR11","doi-asserted-by":"publisher","first-page":"e774","DOI":"10.1371\/journal.pntd.0000774","volume":"4","author":"CA Guerra","year":"2010","unstructured":"Guerra CA, Howes RE, Patil AP, Gething PW, Van Boeckel TP, Temperley WH, et al. The international limits and population at risk of Plasmodium vivax transmission in 2009. PLoS Negl Trop Dis. 2010;4:e774.","journal-title":"PLoS Negl Trop Dis."},{"key":"3393_CR12","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.parint.2013.07.002","volume":"62","author":"S Jeong","year":"2013","unstructured":"Jeong S, Yang HW, Yoon YR, Lee WK, Lee YR, Jha BK, et al. Evaluation of the efficacy of chloroquine chemoprophylaxis for vivax malaria among Republic of Korea military personnel. Parasitol Int. 2013;62:494\u20136.","journal-title":"Parasitol Int"},{"key":"3393_CR13","doi-asserted-by":"publisher","first-page":"707","DOI":"10.3346\/jkms.2005.20.5.707","volume":"20","author":"JS Yeom","year":"2005","unstructured":"Yeom JS, Ryu SH, Oh S, Choi DH, Song KJ, Oh YH, et al. Evaluation of anti-malarial effects of mass chemoprophylaxis in the Republic of Korea army. J Korean Med Sci. 2005;20:707\u201312.","journal-title":"J Korean Med Sci"},{"key":"3393_CR14","doi-asserted-by":"publisher","first-page":"e00011","DOI":"10.1128\/CMR.00011-19","volume":"32","author":"JK Baird","year":"2019","unstructured":"Baird JK. 8-Aminoquinoline therapy for latent malaria. Clin Microbiol Rev. 2019;32:e00011\u20139.","journal-title":"Clin Microbiol Rev"},{"key":"3393_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0035-9203(85)90221-4","volume":"79","author":"WA Krotoski","year":"1985","unstructured":"Krotoski WA. Discovery of the hypnozoite and a new theory of malarial relapse. Trans R Soc Trop Med Hyg. 1985;79:1\u201311.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"3393_CR16","doi-asserted-by":"publisher","first-page":"e1002224","DOI":"10.1371\/journal.pmed.1002224","volume":"14","author":"CS Chu","year":"2017","unstructured":"Chu CS, Bancone G, Moore KA, Win HH, Thitipanawan N, Po C, et al. Haemolysis in G6PD heterozygous females treated with primaquine for Plasmodium vivax malaria: a nested cohort in a trial of radical curative regimens. PLoS Med. 2017;14:e1002224.","journal-title":"PLoS Med."},{"key":"3393_CR17","doi-asserted-by":"publisher","first-page":"4123","DOI":"10.1182\/blood-2012-03-416032","volume":"120","author":"A Pamba","year":"2012","unstructured":"Pamba A, Richardson ND, Carter N, Duparc S, Premji Z, Tiono AB, et al. Clinical spectrum and severity of hemolytic anemia in glucose 6-phosphate dehydrogenase-deficient children receiving dapsone. Blood. 2012;120:4123\u201333.","journal-title":"Blood"},{"key":"3393_CR18","doi-asserted-by":"publisher","first-page":"702","DOI":"10.4269\/ajtmh.16-0779","volume":"97","author":"R Rueangweerayut","year":"2017","unstructured":"Rueangweerayut R, Bancone G, Harrell EJ, Beelen AP, Kongpatanakul S, Mohrle JJ, et al. Hemolytic potential of tafenoquine in female volunteers heterozygous for glucose-6-phosphate dehydrogenase (G6PD) deficiency (G6PD Mahidol variant) versus G6PD-normal volunteers. Am J Trop Med Hyg. 2017;97:702\u201311.","journal-title":"Am J Trop Med Hyg"},{"key":"3393_CR19","first-page":"446","volume":"45","author":"MA Jang","year":"2015","unstructured":"Jang MA, Kim JY, Lee KO, Kim SH, Koo HH, Kim HJ. A Novel de novo mutation in the G6PD gene in a Korean boy with glucose-6-phosphate dehydrogenase deficiency: case report. Ann Clin Lab Sci. 2015;45:446\u20138.","journal-title":"Ann Clin Lab Sci"},{"key":"3393_CR20","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3346\/jkms.1992.7.1.71","volume":"7","author":"MK Kim","year":"1992","unstructured":"Kim MK, Yang CH, Kang SH, Lyu CJ, Kim KY. Glucose-6-phosphate dehydrogenase deficiency\u2014report of 4 cases. J Korean Med Sci. 1992;7:71\u20135.","journal-title":"J Korean Med Sci"},{"key":"3393_CR21","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3343\/alm.2017.37.2.108","volume":"37","author":"J Lee","year":"2017","unstructured":"Lee J, Park J, Choi H, Kim J, Kwon A, Jang W, et al. Genetic Profiles of Korean patients with glucose-6-phosphate dehydrogenase deficiency. Ann Lab Med. 2017;37:108\u201316.","journal-title":"Ann Lab Med."},{"key":"3393_CR22","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1093\/genetics\/162.4.1849","volume":"162","author":"MA Saunders","year":"2002","unstructured":"Saunders MA, Hammer MF, Nachman MW. Nucleotide variability at G6PD and the signature of malarial selection in humans. Genetics. 2002;162:1849\u201361.","journal-title":"Genetics"},{"key":"3393_CR23","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1111\/j.1445-5994.2011.02456.x","volume":"41","author":"F Amini","year":"2011","unstructured":"Amini F, Ismail E, Zilfalil BA. Prevalence and molecular study of G6PD deficiency in Malaysian Orang Asli. Intern Med J. 2011;41:351\u20133.","journal-title":"Intern Med J."},{"key":"3393_CR24","first-page":"259","volume":"18","author":"Z Yang","year":"2001","unstructured":"Yang Z, Chu J, Ban G, Huang X, Xu S, Li M. [The genotype analysis of glucose-6-phosphate dehydrogenase deficiency in Yunnan province](in Chinese). Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2001;18:259\u201363.","journal-title":"Zhonghua Yi Xue Yi Chuan Xue Za Zhi."},{"key":"3393_CR25","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1471-2156-10-41","volume":"10","author":"B Moiz","year":"2009","unstructured":"Moiz B, Nasir A, Moatter T, Naqvi ZA, Khurshid M. Population study of 1311 C\/T polymorphism of Glucose 6 Phosphate Dehydrogenase gene in Pakistan\u2014an analysis of 715 X-chromosomes. BMC Genet. 2009;10:41.","journal-title":"BMC Genet"},{"key":"3393_CR26","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1006\/bcmd.1995.0010","volume":"21","author":"E Beutler","year":"1995","unstructured":"Beutler E, Westwood B, Melemed A, Dal Borgo P, Margolis D. Three new exon 10 glucose-6-phosphate dehydrogenase mutations. Blood Cells Mol Dis. 1995;21:64\u201372.","journal-title":"Blood Cells Mol Dis"},{"key":"3393_CR27","first-page":"1008","volume":"47","author":"E Beutler","year":"1990","unstructured":"Beutler E, Kuhl W. The NT 1311 polymorphism of G6PD: G6PD Mediterranean mutation may have originated independently in Europe and Asia. Am J Hum Genet. 1990;47:1008\u201312.","journal-title":"Am J Hum Genet"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-020-03393-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-020-03393-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-020-03393-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T20:23:44Z","timestamp":1630441424000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-020-03393-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["3393"],"URL":"https:\/\/doi.org\/10.1186\/s12936-020-03393-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-32936\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-32936\/v2","asserted-by":"object"}]},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,1]]},"assertion":[{"value":"20 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the ethics committee of the Armed Forces Medical Command (AFMC) of the ROK (Approval No. AFMC-17-IRB-023). Written informed consent was obtained from each participant.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"317"}}